Cloud P Paweletz

Acquired EGFR C797S mediates resistance to AZD9291 in advanced non-small cell lung cancer harboring EGFR T790M

Aleksandra Markovets, J Carl Barrett, Geoffrey R Oxnard, 2015, Nature Medicine.

Clinical Proteomics for Cancer Biomarker Discovery and Therapeutic Targeting

Emanuel F Petricoin, Lance A Liotta, E. Petricoin, 2002, Technology in cancer research & treatment.

Quantitative analysis of complex peptide mixtures using FTMS and differential mass spectrometry

Matthew C Wiener, Fanyu Meng, R. Hendrickson, 2007, Journal of the American Society for Mass Spectrometry.

Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer

Emanuel F Petricoin, John W Gillespie, Lance A Liotta, 2003, Proteomics.

Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays.

Emanuel F Petricoin, Lance A Liotta, Tina Chen, 2002, Briefings in functional genomics & proteomics.

Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry.

Matthew C Wiener, Fanyu Meng, R. Hendrickson, 2010, Journal of proteome research.

Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors

Theresa Zhang, John Rush, Igor Feldman, 2010, Science Translational Medicine.

Protein microarray platforms for clinical proteomics

Harvey B Pollard, D. Jacobowitz, C. Paweletz, 2007, Proteomics. Clinical applications.

3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade.

Roger D Kamm, Valeria Chiono, Amir R Aref, 2018, Lab on a chip.